Withdraw Exkivity
![Takeda Recalls Global Lung Cancer Medication, Exkivity, Following Confirmatory Trial Failure](https://pharmtales.com/wp-content/uploads/2023/10/Takeda-Recalls-Global-Lung-Cancer-Medication-Exkivity-Following-Confirmatory-Trial-Failure.jpg)
Takeda withdraw Global Lung Cancer Medication, Exkivity, Following Confirmatory Trial Failure
Anika Sharma
Following a disappointing outcome in a confirmatory trial earlier this year, Takeda has decided to discontinue its targeted non-small cell ...